User profiles for Jeff M. Michalski
Jeff MichalskiWashington University Verified email at wustl.edu Cited by 35773 |
[HTML][HTML] Predicting the outcome of salvage radiation therapy for recurrent prostate cancer after radical prostatectomy
…, EA Klein, MS Anscher, JM Michalski… - Journal of clinical …, 2007 - ncbi.nlm.nih.gov
Purpose An increasing serum prostate-specific antigen (PSA) level is the initial sign of
recurrent prostate cancer among patients treated with radical prostatectomy. Salvage radiation …
recurrent prostate cancer among patients treated with radical prostatectomy. Salvage radiation …
Treatment of non-metastatic muscle-invasive bladder cancer: AUA/ASCO/ASTRO/SUO guideline
Purpose : This multidisciplinary, evidence-based guideline for clinically non-metastatic
muscle-invasive bladder cancer focuses on the evaluation, treatment and surveillance of muscle-…
muscle-invasive bladder cancer focuses on the evaluation, treatment and surveillance of muscle-…
Radiation dose–volume effects in radiation-induced rectal injury
JM Michalski, H Gay, A Jackson, SL Tucker… - International Journal of …, 2010 - Elsevier
The available dose/volume/outcome data for rectal injury were reviewed. The volume of
rectum receiving ≥60Gy is consistently associated with the risk of Grade ≥2 rectal toxicity or …
rectum receiving ≥60Gy is consistently associated with the risk of Grade ≥2 rectal toxicity or …
[HTML][HTML] Randomized phase III noninferiority study comparing two radiotherapy fractionation schedules in patients with low-risk prostate cancer
…, AB Shah, DP D'Souza, JM Michalski… - Journal of Clinical …, 2016 - ncbi.nlm.nih.gov
Purpose Conventional radiotherapy (C-RT) treatment schedules for patients with prostate
cancer typically require 40 to 45 treatments that take place from> 8 to 9 weeks. Preclinical and …
cancer typically require 40 to 45 treatments that take place from> 8 to 9 weeks. Preclinical and …
Pelvic normal tissue contouring guidelines for radiation therapy: a Radiation Therapy Oncology Group consensus panel atlas
…, D Gaffney, AN Viswanathan, JM Michalski - International Journal of …, 2012 - Elsevier
PURPOSE: To define a male and female pelvic normal tissue contouring atlas for Radiation
Therapy Oncology Group (RTOG) trials. METHODS AND MATERIALS: One male pelvis …
Therapy Oncology Group (RTOG) trials. METHODS AND MATERIALS: One male pelvis …
[HTML][HTML] Contemporary update of a multi-institutional predictive nomogram for salvage radiotherapy after radical prostatectomy
…, TM Pisansky, JM Michalski… - Journal of clinical …, 2016 - scholarship.miami.edu
Purpose We aimed to update a previously published, multi-institutional nomogram of outcomes
for salvage radiotherapy (SRT) following radical prostatectomy (RP) for prostate cancer, …
for salvage radiotherapy (SRT) following radical prostatectomy (RP) for prostate cancer, …
Predicting dose‐volume histograms for organs‐at‐risk in IMRT planning
LM Appenzoller, JM Michalski, WL Thorstad… - Medical …, 2012 - Wiley Online Library
Purpose: The objective of this work was to develop a quality control (QC) tool to reduce
intensity modulated radiotherapy (IMRT) planning variability and improve treatment plan quality …
intensity modulated radiotherapy (IMRT) planning variability and improve treatment plan quality …
Development of RTOG consensus guidelines for the definition of the clinical target volume for postoperative conformal radiation therapy for prostate cancer
JM Michalski, C Lawton, I El Naqa, M Ritter… - International Journal of …, 2010 - Elsevier
PURPOSE: To define a prostate fossa clinical target volume (PF-CTV) for Radiation
Therapy Oncology Group (RTOG) trials using postoperative radiotherapy for prostate cancer. …
Therapy Oncology Group (RTOG) trials using postoperative radiotherapy for prostate cancer. …
11C-acetate PET imaging of prostate cancer: detection of recurrent disease at PSA relapse
…, BA Siegel, KC Fischer, JM Michalski… - Journal of Nuclear …, 2003 - Soc Nuclear Med
Patients with rising prostate-specific antigen (PSA) levels after definitive local therapy of
prostate carcinoma present a diagnostic dilemma. A local recurrence would be amenable to …
prostate carcinoma present a diagnostic dilemma. A local recurrence would be amenable to …
The addition of androgen deprivation therapy and pelvic lymph node treatment to prostate bed salvage radiotherapy (NRG Oncology/RTOG 0534 SPPORT): an …
Background In men with a detectable prostate-specific antigen (PSA) level after prostatectomy
for prostate cancer, salvage prostate bed radiotherapy (PBRT) results in about 70% of …
for prostate cancer, salvage prostate bed radiotherapy (PBRT) results in about 70% of …